1. Home
  2. SPRY vs TPB Comparison

SPRY vs TPB Comparison

Compare SPRY & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • TPB
  • Stock Information
  • Founded
  • SPRY 2015
  • TPB 1988
  • Country
  • SPRY United States
  • TPB United States
  • Employees
  • SPRY N/A
  • TPB N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • TPB Tobacco
  • Sector
  • SPRY Health Care
  • TPB Consumer Discretionary
  • Exchange
  • SPRY Nasdaq
  • TPB Nasdaq
  • Market Cap
  • SPRY 1.8B
  • TPB 1.8B
  • IPO Year
  • SPRY N/A
  • TPB 2016
  • Fundamental
  • Price
  • SPRY $9.65
  • TPB $102.59
  • Analyst Decision
  • SPRY Strong Buy
  • TPB Strong Buy
  • Analyst Count
  • SPRY 5
  • TPB 5
  • Target Price
  • SPRY $31.00
  • TPB $77.00
  • AVG Volume (30 Days)
  • SPRY 3.1M
  • TPB 312.3K
  • Earning Date
  • SPRY 11-12-2025
  • TPB 11-06-2025
  • Dividend Yield
  • SPRY N/A
  • TPB 0.29%
  • EPS Growth
  • SPRY N/A
  • TPB N/A
  • EPS
  • SPRY N/A
  • TPB N/A
  • Revenue
  • SPRY $112,339,000.00
  • TPB $407,441,000.00
  • Revenue This Year
  • SPRY N/A
  • TPB $25.18
  • Revenue Next Year
  • SPRY $182.40
  • TPB $9.03
  • P/E Ratio
  • SPRY N/A
  • TPB N/A
  • Revenue Growth
  • SPRY 22367.80
  • TPB 37.09
  • 52 Week Low
  • SPRY $9.39
  • TPB $38.50
  • 52 Week High
  • SPRY $18.90
  • TPB $104.76
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 47.12
  • TPB 65.67
  • Support Level
  • SPRY $9.97
  • TPB $100.47
  • Resistance Level
  • SPRY $10.78
  • TPB $104.76
  • Average True Range (ATR)
  • SPRY 0.57
  • TPB 3.16
  • MACD
  • SPRY -0.54
  • TPB -0.25
  • Stochastic Oscillator
  • SPRY 72.14
  • TPB 77.96

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About TPB Turning Point Brands Inc.

Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.

Share on Social Networks: